IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseasesPing Shen, Simon Fillatreau, Rui Li et al.|Nature|2014Cited by 1k
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cellsTom A. Barr, David Gray, Ping Shen et al.|The Journal of Experimental Medicine|2012Cited by 651
Activation of <scp>CD</scp>4<sup>+</sup><scp>F</scp>oxp3<sup>+</sup> regulatory <scp>T</scp> cells proceeds normally in the absence of <scp>B</scp> cells during <scp>EAE</scp>Kai Hoehlig, Simon Fillatreau, Ping Shen et al.|European Journal of Immunology|2012Cited by 37
Antigen receptor‐engineered Tregs inhibit CNS autoimmunity in cell therapy using nonredundant immune mechanisms in miceJelka Pohar, Simon Fillatreau, Richard A. O’Connor et al.|European Journal of Immunology|2022Cited by 12
IL-6 from CD1d(hi) B cell drives the pathogenic Th17 response during EAETom A. Barr, David F. Gray, V. Lampropoulo et al.|Immunology|2010Cited by 0